Index of HIV/AIDS-related articles

This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition.

A

AACTG – acquired immunityacquired immunodeficiency syndrome (AIDS) – ACT UP/Golden Gate – active immunityacupunctureacute HIV infectionAcute HIV Infection and Early Diseases Research Program (AIEDRP) – ADAP – ADCadenopathyadherenceadjuvant – administration – Adult AIDS Clinical Trials Group (AACTG) – adverse drug reactionaerosolizedAETCagammaglobulinemiaAgency for Healthcare Research and Quality (AHRQ) – AHRQAIDSAIDS ArmsAIDS dementia complex (ADC) – AIDS Drug Assistance Programs (ADAP) – AIDS education and training centers (AETC) – AIDS orphan – AIDS research advisory committee (ARAC) – AIDS service organization (ASO) – The AIDS Show – AIDS Vaccine 200 – AIDS Vaccine Advocacy Coalition – AIDS wasting syndromeAIDS-related cancerAIDS-related complex (ARC) – alkaline phosphatase – alopecia – alpha interferon (INFa) – alternative medicinealveolaramebiasis – amino acids – anaphylactic shockanemiaanergyangiogenesisangiomatosisanorexiaantenatalantibioticantibodiesantibody-dependent cell-mediated cytotoxicity (ADCC) – antibody-mediated immunityantifungal medicationantigenantigen presentationantigen-presenting cell (APC) – antineoplasticantiprotozoalantiretroviral drugsantisense drugsantitoxinsAntiviral drugaphasiaaphthous ulcer – apoptosis – approved drugsARCArmenicumARTarthralgiaASOaspergillosisassembly and buddingasymptomaticataxiaattenuated – autoantibody – autoimmunizationautoinoculationautologousavascular necrosis (AVN) – AVN

B

B-cell lymphomaB cellsB lymphocytes (B cells) – bactericidal – bacteriostatic – bacterium – baculovirusbaselinebasophilbDNA testbeta-2 microglobulin (β2M) – bilirubinbioavailabilitybiological response modifiers (BRMs) – biopsybiotechnologyblinded study – blips – blood–brain barrierbody fat redistribution (BFR) syndromebody fluidsbone marrowbone marrow suppressionboosterbranched DNA assaybreakthrough infection – Broadway Cares/Equity Fights AIDS – bronchoscopy – budding – buffalo hump – bugchasing and giftgivingBurkitt's lymphoma

C

C-T scan (computed tomography scan) – cachexiaCanadian Foundation for AIDS ResearchcandidacandidiasiscarcinogenCAT scanCCR5CD4 (T4) or CD4 + cellsCDC National Prevention Information Network (CDC-NPIN) – cell lines – cell-mediated immunity (CMI) – cellular immunity – Centers for Disease Control and Prevention (CDC) – Centers for Medicare and Medicaid Services (CMS) – central nervous systemcerebrumcerebrospinal fluid (CSF) – cervical cancercervical dysplasiacervical intraepithelial neoplasia (CIN1, CIN2, CIN3) – cervixchancroid – chemokines – chemoprophylaxischemotherapyChlamydiachronic idiopathic demyelinating polyneuropathy (CIPD) – circumoral paresthesia – clade – clinical endpointclinical latencyclinical practice guidelinesclinical trialclinicaltrials.gov – cloning – CMSCMVCNSco-receptorscoccidioidomycosis – codon – cofactors – cognitive impairmentcohortcolitiscombination therapy – community planning – Community Programs for Clinical Research on AIDS (CPCRA) – community-based clinical trial (CBCT) – community-based organization (CBO) – compassionate usecomplementcomplement cascadecomplementary and alternative therapycomplete blood count (CBC) – computed tomography scan (C-T scan) – concomitant drugscondylomacondyloma acuminatumcontagiouscontraindicationcontrolled trialscore – core protein – correlates of immunity/correlates of protection – creatinine – cross-resistancecryotherapycryptococcal meningitiscryptococcosisCryptococcus neoformanscryptosporidiosisCryptosporidiumCSFCTLcutaneous – CXCR4 – cytokinescytomegalovirus (CMV) – Cytomegalovirus retinitiscytopeniacytotoxiccytotoxic T lymphocyte (CTL)

D

DAIDS – data safety and monitoring board (DSMB) – deletiondementiademyelinationdendritedendritic cells – deoxyribonucleic acid (DNA) – Department of Health and Human Services (DHHS/HHS or DHHS) – desensitizationdiabetes mellitus (DM) – diagnosis – diarrheadiplopia – dissemination – division of acquired immunodeficiency syndrome (DAIDS) – DNA – Domain (biology) – dose-ranging studydose-response relationshipdouble-blind studydrug resistancedrug-drug interactionDSMBDuffy antigen systemdysplasiadyspnea

E

efficacy – empirical – encephalitisend-stage disease – endemic – endogenous – endoscopyendotoxinendpointentericenteritisentry inhibitors – Env – envelope – enzyme – enzyme-linked immunosorbent assay (ELISA) – eosinophileosinophilic folliculitisepidemicepidemiological surveillanceepidemiologyepithelium – epitope – Epstein-Barr virus (EBV) – erythemaerythema multiformeerythrocytes – etiology – exogenous – exotoxinexpanded accessexperimental drug – expression system

F

fat redistributionFDA FDCfloatersfolliclefollicular dendritic cells (FDCs) – Food and Drug Administration (United States) functional antibodyfungus – fusin – fusion inhibitorfusion mechanism – fusion peptide

G

GAGgamma globulingamma interferonganglion – GART – gastrointestinal (GI) – gene – gene therapy – genetic engineering – genital ulcer diseasegenital wartsgenitourinary tract – genome – genotypic assay – germinal centersgiardiasis – globulins – glycoprotein – gonorrhea – gp120 (gp120) – gp160 (gp160) – gp41 (gp41) – granulocytegranulocyte macrophage-colony stimulating factor (GM-CSF) – granulocyte-colony stimulating factor (G-CSF) – granulocytopenia

H

HAARThairy leukoplakia – half-life – HAM/TSPHealth Care Financing Administration (HCFA) – Health Resources and Services Administration (HRSA) – HELLP syndromehelper T cellshelper/suppressor ratio (of T cells) – hematocrithematotoxichemoglobinhemolysishemophiliahepatichepatic steatosishepatitishepatitis C and HIV coinfectionhepatomegalyherpes simplex virus 1 (HSV-1) – herpes simplex virus 2 (HSV-2) – herpes varicella zoster virus (VZV) – herpes viruseshighly active antiretroviral therapy (HAART) – histocompatibility testinghistoplasmosisHIV diseaseHIV prevention trials network (HPTN) – HIV set point – HIV vaccine trials network (HVTN) – HIV-1HIV-2HIV-associated dementiaHIV-related tuberculosisHLAHodgkin's diseaseholistic medicine – homology (biology) – hormonehosthost factorsHPTNHPVHRSAHTLV-IHTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) – HTLV-IIhuman growth hormone (HGH) – human immunodeficiency virus type 1 (HIV-1) – human immunodeficiency virus type 2 (HIV-2) – human leukocyte antigens (HLA) – human papilloma virus (HPV) – human T cell lymphotropic virus type I (HTLV-I) – human T cell lymphotropic virus type II (HTLV-II) – humoral immunity – HVTN – hydroxyureahypergammaglobulinemiahyperglycemiahyperlipidemiahyperplasiahyperthermiahypogonadism – hypothesis – hypoxia

I

idiopathicidiopathic thrombocytopenia purpuraIHSimmune compleximmune deficiency/immunodeficiencyimmune responseimmune systemimmune thrombocytopenic purpuraimmunityimmunizationimmunocompetentimmunocompromisedimmunodeficiencyimmunogenimmunogenicityimmunoglobulin (Ig) – immunoglobulin A (IgA) – immunoglobulin D (IGD) – immunoglobulin E (IGE) – immunoglobulin G (IGG) – immunoglobulin M (IGM) – immunomodulatorimmunostimulantimmunosuppressionimmunotherapyimmunotoxinin vitro – in vivo – incidenceIncubation periodINDIndian Health Service (IHS) – infectioninfectiousinformed consent – infusion – inoculation – institutional review board (IRB) – integrase – integrase inhibitors – interaction – interferon – interleukin-1 (IL-1) – interleukin-2 (IL-2) – interleukin-4 (IL-4) – interleukin-12 (IL-12) – interleukins – International Center for Research on Women – intramuscular (IM) – intravenousintravenous immunoglobulin (IVIG) – intravitrealInvestigational New Drug (IND) – IRBITPIVIG

J

jaundice – JC virus

K

Kaposi's sarcoma (KS) – Karnofsky scorekiller T cellsKSHVKupffer cells

L

Langerhans cellsLASlentiviruslesionleukocytesleukocytosisleukopenialeukoplakiaLFTLIP – lipid – lipodystrophyliposomeslive vector vaccineliver function test (LFT) – long terminal repeat sequence (LTR) – long-term nonprogressors – LTR – lumbarlumbar puncturelymphlymph nodeslymphadenopathy syndrome (LAS) – lymphatic vesselslymphocytelymphoid interstitial pneumonitis (LIP) – lymphoid organslymphoid tissue – lymphokine-activated killer cells (LAK) – lymphokineslymphomalymphopenialymphoproliferative response – lysis

M

MACmacrophage – macrophage-tropic virus – magnetic resonance imaging (MRI) – MAImaintenance therapy – major histocompatibility complex (MHC) – malabsorption syndromemalaisemalignantmast cellMedlinePlusmega-HAARTmemory T cellsmeningesmeningitismessenger RNAmetabolismmetastasis – MHC – microbesmicrobicideMicrosporidiosismitochondriamitochondrial toxicity – molecule – molluscum contagiosummonocytemononeuritis multiplex (MM) – monovalent vaccinemorbidityMRImucocutaneousmucosamucosal immunitymucous membraneMulticenter AIDS Cohort Studymulti-drug rescue therapymultiple drug-resistant tuberculosis (MDR-TB) – mutationmyalgiamycobacteriummycobacterium avium complex (MAC) – mycosismyelinmyelopathymyelosuppressionmyelotoxicmyocardialmyopathy

N

NATNational Cancer Institute (NCI) – National Institute of Allergy and Infectious Diseases (NIAID) – National Institute of Child Health and Human Development (NICHD) – National Institutes of Health (NIH) – National Library of Medicine (NLM) – National Prevention Information Network (NPIN) – natural history studynatural killer cells (NK cells) – NCINew Drug Applicationnebulized – Nef – neoplasmnephrotoxicneuralgianeurological complications of AIDSneuropathyneutralizationneutralizing antibodyneutralizing domainneutropenianeutrophilNew Drug Application (NDA) – New York Cares – NIAIDNICHDnight sweatNIHNK cell – NLM – NNRTInon-Hodgkin's lymphoma (NHL) – non-nucleoside reverse transcriptase inhibitors (NNRTI) – non-steroidal anti-inflammatory drugs (NSAID) – NRTI – nucleic acid – nucleic acid test – nucleocapsid – nucleoli – nucleoside – nucleoside analognucleoside reverse transcriptase inhibitors (NRTI) – nucleotide – nucleotide analogs – nucleus – null cell

O

ocularoff-label useoncologyopen-label trialopportunistic infectionsoral hairy leukoplakia (OHL) – organelle – oropharyngealorphan drugsosteonecrosisosteopenia

P

P24 – package insertpalliativepalliative carepancreaspancreatitispancytopeniapandemicpap smearpapilloma – parallel track – parasiteparenteralparesthesiapassive immunitypassive immunotherapypathogenpathogenesisPBMCPCPPCR – Pediatric AIDS Clinical Trial Group (PACTG) – pelvic inflammatory diseasepeptideperianalperinatalperinatal transmissionperipheral neuritisperipheral neuropathypersistent generalized lymphadenopathyPGLphagocyte – phagocytosis – pharmacokineticsphase I trialsphase II trialsphase III trialsphase IV trialsphotosensitivityPHSpituitary glandplaceboplacebo controlled studyplacebo effectplasmaplasma cellsplateletsPMLPneumocystis jiroveci pneumonia (formerly Pneumocystis carinii or PCP) – POL – polymerase – polymerase chain reaction (PCR)polyneuritispolypeptidepolyvalent vaccinepost-exposure prophylaxis (PEP) – PPD testpre-conception counselingpreclinical – precursor cells – prevalenceprimary HIV infection – primary isolate – primaquineproctitisprodromeprodrugprogressive multifocal leukoencephalopathy (PML) – prophylactic drugprophylaxis – protease – protease inhibitorsprotease-sparing regimen – proteins – protocolprotozoa – provirus – prurituspseudo-Cushing's syndrome – pseudovirion – PUBMED – pulmonarypurified protein derivative (PPD)

R

radiology – randomized trial – reboundreceptor (immunology)recombinant – recombinant DNA – recombinant DNA technology – regulatory genesregulatory T cellsremissionrenalrescue therapyresistanceretinaretinal detachmentretinitis – retrovirus – REV – reverse transcriptase – ribonucleic acid (RNA) – ribosome – RNA – route of administration – RT-PCR – RTI – Ryan White C.A.R.E. act

S

safe sexsafer sexsalmonellasalvage therapySAMHSAsarcomaseborrheic dermatitissecondary prophylaxissepsisseroconversionserologic testseroprevalenceserosortingserostatusserum – serum glutamic oxaloacetic transaminase (SGOT) – serum glutamic pyruvate transaminase (SGPT) – sexually transmitted disease (STD) – shinglesSHIVside effectssimian immunodeficiency virus (SIV) – sinusitis – social integration SITSIV – Special Projects of National Significance (SPNS) – spinal tapspleensplenomegalysputum analysisstandard of carestaphylococcusSTDstem cells (FDCs) – steroidStevens–Johnson syndromeSTIstomatitisstrain – stratification – structured intermittent therapy (SIT) – structured treatment interruption (STI) – study endpointsubarachnoid spacesubclinical infectionsubcutaneous (SQ) – Substance Abuse and Mental Health Services Administration (SAMHSA) – subunit HIV vaccinesulfa drug – sulfonamides – superantigen – suppressor T cellsurrogate marker – surveillance – susceptiblesymptomssyncytiumsyndrome – synergy – synergistic – synthesis – syphilissystemic

T

T cells (T lymphocytes) – T lymphocyte proliferation assayT lymphocytesT suppressor cellsT4 cells (T-helper cells) – T8 cellsTanner staging – TAT – TB – template – TeachAids – teratogenicitytestosteronetherapeutic HIV vaccinethrombocytopeniathrush – thymosin – thymustissuetitertoxicitytoxoplasmic encephalitistoxoplasmosistransaminase – transcription – transfusion – translation – transmissiontransplacentaltreatment IND – triglycerides – tuberculin skin test (TST) – tuberculosis (TB) – tumor necrosis factor (TNF)

V

V3 loopvaccinationvaccinevacciniavaginal candidiasisvalley fevervariable regionvaricella zoster virus (VZV) – vectorvertical transmissionviral burden – viral core – viral culture – viral envelope – viral loadviremiaviricidevirion – virology – virusvisceral

W

wasting syndrome – Western blot – white blood cells – wild-type virus – window periodWomen's Interagency HIV Study (WIHS) – World AIDS DayWorld AIDS Vaccine Day

Y

yeast infection – Youth Against AIDS

Z

zinc finger inhibitor – zinc fingers

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.